Upregulated BCAR4 has been reported as a marker for poor prognosis in colon cancer, gastric cancer and cervical cancer.18–20 Functional studies suggested BCAR4 as a potential oncogene in breast, lung and brain cancers demonstrating enhanced proliferation and tumour formation by BCAR4.14,21,22. Here, BCAR4 is linked to colonic neoplasm.